Substance / Medication

Sapropterin dihydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

10 trials linked to this intervention

10
Total Trials
3
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Sapropterin dihydrochloride for phenylketonuria.
Somaraju Usha Rani, Merrin Marcus · Cochrane Database Syst Rev · 2015
PMID: 25812600Meta-AnalysisFull text (PMC)
Sapropterin dihydrochloride for phenylketonuria.
Somaraju Usha Rani, Merrin Marcus · Cochrane Database Syst Rev · 2012
PMID: 23235653Meta-Analysis
Sapropterin dihydrochloride for phenylketonuria.
Somaraju Usha Rani, Merrin Marcus · Cochrane Database Syst Rev · 2010
PMID: 20556789Meta-Analysis
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients.
Utz Jeanine R Jarnes, Lorentz Cindy Pham, Markowitz Dorothy et al. · Mol Genet Metab · 2012
PMID: 22112818RCT
Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension.
Robbins Ivan M, Hemnes Anna R, Gibbs J Simon et al. · Exp Lung Res · 2011
PMID: 21077779Trial
Safety of extended treatment with sapropterin dihydrochloride in patients with phenylketonuria: results of a phase 3b study.
Burton Barbara K, Nowacka Maria, Hennermann Julia B et al. · Mol Genet Metab · 2011
PMID: 21646032Trial
Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
Vernon H J, Koerner C B, Johnson M R et al. · Mol Genet Metab · 2010
PMID: 20418136TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sapropterin dihydrochloride (substance)
SNOMED CT
434239009
UMLS CUI
C1996349

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
10
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Sapropterin dihydrochloride: Uses, Evidence & Side Effects | Ltrl